10.6084/m9.figshare.c.3734302_D1.v1 Sardar Sindhu Sardar Sindhu Nadeem Akhter Nadeem Akhter Hossein Arefanian Hossein Arefanian Areej Al-Roub Areej Al-Roub Shamsha Ali Shamsha Ali Ajit Wilson Ajit Wilson Asma Al-Hubail Asma Al-Hubail Shaima Al-Beloushi Shaima Al-Beloushi Saad Al-Zanki Saad Al-Zanki Rasheed Ahmad Rasheed Ahmad Additional file 1: Figure S1. of Increased circulatory levels of fractalkine (CX3CL1) are associated with inflammatory chemokines and cytokines in individuals with type-2 diabetes Springer Nature 2017 Fractalkine CX3CL1 Chemokines Cytokines Inflammation Obesity Type-2 diabetes 2017-04-04 05:00:00 Figure https://springernature.figshare.com/articles/figure/Additional_file_1_Figure_S1_of_Increased_circulatory_levels_of_fractalkine_CX3CL1_are_associated_with_inflammatory_chemokines_and_cytokines_in_individuals_with_type-2_diabetes/4817722 Plasma levels of fractalkine and selective inflammatory cytokines were measured in 23 type-2 diabetic (T2D) and 24 non-diabetic individuals using magnetic bead premixed 41-plex immune assays as described in Methods. The data show that in non-diabetic individuals, systemic fractalkine levels did not associate with (A) G-CSF (r = 0.31 P = 0.14); (B) IFN-α2 (r = 0.23 P = 0.28); (C) IL-17A (r = 0.10 P = 0.78); and (D) IL-6 (r = 0.18 P = 0.45). (TIF 716 kb)